These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30144894)

  • 1. Probiotics in cystic fibrosis patients: A double blind crossover placebo controlled study: Pilot study from the ESPGHAN Working Group on Pancreas/CF.
    Van Biervliet S; Hauser B; Verhulst S; Stepman H; Delanghe J; Warzee JP; Pot B; Vandewiele T; Wilschanski M
    Clin Nutr ESPEN; 2018 Oct; 27():59-65. PubMed ID: 30144894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic supplementation in children with cystic fibrosis-a systematic review.
    Ananthan A; Balasubramanian H; Rao S; Patole S
    Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
    del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
    J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis.
    Fallahi G; Motamed F; Yousefi A; Shafieyoun A; Najafi M; Khodadad A; Farhmand F; Ahmadvand A; Rezaei N
    Turk J Pediatr; 2013; 55(5):475-8. PubMed ID: 24382526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.
    Flass T; Tong S; Frank DN; Wagner BD; Robertson CE; Kotter CV; Sokol RJ; Zemanick E; Accurso F; Hoffenberg EJ; Narkewicz MR
    PLoS One; 2015; 10(2):e0116967. PubMed ID: 25658710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus reuteri ATCC55730 in cystic fibrosis.
    Di Nardo G; Oliva S; Menichella A; Pistelli R; De Biase RV; Patriarchi F; Cucchiara S; Stronati L
    J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):81-6. PubMed ID: 24121143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Lactobacillus reuteri on pulmonary function test and growth of cystic fibrosis patients.
    Tabatabaii SA; Khanbabaee G; Sadr S; Farahbakhsh N; Modarresi SZ; Pourghasem M; Hajipour M
    J Sci Food Agric; 2024 Nov; 104(14):9056-9061. PubMed ID: 38982876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral reduced L-glutathione improves growth in pediatric cystic fibrosis patients.
    Visca A; Bishop CT; Hilton S; Hudson VM
    J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):802-10. PubMed ID: 25633497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
    Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does probiotic supplementation affect pulmonary exacerbation and intestinal inflammation in cystic fibrosis: a systematic review of randomized clinical trials.
    Nikniaz Z; Nikniaz L; Bilan N; Somi MH; Faramarzi E
    World J Pediatr; 2017 Aug; 13(4):307-313. PubMed ID: 28470579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study.
    Weiss B; Bujanover Y; Yahav Y; Vilozni D; Fireman E; Efrati O
    Pediatr Pulmonol; 2010 Jun; 45(6):536-40. PubMed ID: 20503277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The altered gut microbiota in adults with cystic fibrosis.
    Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
    BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study.
    de Roos NM; van Hemert S; Rovers JMP; Smits MG; Witteman BJM
    Eur J Clin Nutr; 2017 Dec; 71(12):1455-1462. PubMed ID: 28537581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis.
    Roca M; Masip E; Colombo C; Boon M; Hulst JM; Garriga M; de Koning BAE; Bulfamante A; de Boeck K; Ribes-Koninckx C; Calvo-Lerma J
    Arch Dis Child; 2024 Jun; 109(7):552-556. PubMed ID: 38123920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study.
    Bruzzese E; Raia V; Spagnuolo MI; Volpicelli M; De Marco G; Maiuri L; Guarino A
    Clin Nutr; 2007 Jun; 26(3):322-8. PubMed ID: 17360077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Bifidobacteria enrichment following oral Lactobacillus-supplementation is associated with clinical improvements in children with cystic fibrosis.
    Ray KJ; Santee C; McCauley K; Panzer AR; Lynch SV
    BMC Pulm Med; 2022 Jul; 22(1):287. PubMed ID: 35902830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation.
    Schnapp Z; Hartman C; Livnat G; Shteinberg M; Elenberg Y
    J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):282-284. PubMed ID: 30640865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.
    Vernocchi P; Del Chierico F; Quagliariello A; Ercolini D; Lucidi V; Putignani L
    Nutrients; 2017 Dec; 9(12):. PubMed ID: 29232848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of
    Jung M; Jung S; Kim N; Ahn H; Yun H; Kim KN
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of symbiotic supplementation on fecal calprotectin levels and lactic acid bacteria, Bifidobacteria, Escherichia coli and Salmonella DNA in patients with cervical cancer.
    De Loera Rodríguez LH; Ortiz GG; Rivero Moragrega P; Velázquez Brizuela IE; Santoscoy Gutiérrez JF; Rincón Sánchez AR; Charles Niño CL; Cruz Serrano JA; Celis de la Rosa AJ; Pacheco Moisés FP; Medrano González MDR
    Nutr Hosp; 2018 Dec; 35(6):1394-1400. PubMed ID: 30525855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.